PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.12%
Revenue growth exceeding 1.5x Technology median of 6.10%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
16.17%
Gross profit growth exceeding 1.5x Technology median of 4.59%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
10.22%
EBIT growth of 10.22% while Technology median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
12.17%
Operating income growth exceeding 1.5x Technology median of 1.06%. Joel Greenblatt would see if unique processes drive exceptional profitability.
13.43%
Net income growth exceeding 1.5x Technology median of 3.45%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
8.33%
EPS growth exceeding 1.5x Technology median of 2.44%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
8.70%
Diluted EPS growth near Technology median of 8.70%. Charlie Munger would expect typical industry-level share usage and profit trends.
2.53%
Share change of 2.53% while Technology median is zero. Walter Schloss would see if the modest difference matters long-term.
1.38%
Diluted share change of 1.38% while Technology median is zero. Walter Schloss might see a slight difference in equity issuance policy.
0.49%
Dividend growth of 0.49% while Technology median is flat. Walter Schloss might appreciate at least a modest improvement.
83.58%
OCF growth of 83.58% while Technology is zero. Walter Schloss might see a modest positive difference, which can compound over time.
152.78%
FCF growth of 152.78% while Technology median is zero. Walter Schloss might see a slight edge that could compound over time.
12.26%
10Y revenue/share CAGR below 50% of Technology median of 48.33%. Jim Chanos would suspect deep structural or market share issues.
-16.56%
Negative 5Y CAGR while Technology median is 28.29%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
101.94%
3Y revenue/share growth exceeding 1.5x Technology median of 11.97%. Joel Greenblatt might see a short-term competitive advantage at play.
153.21%
OCF/share CAGR of 153.21% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
94.23%
OCF/share CAGR of 94.23% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
34.58%
3Y OCF/share growth of 34.58% while Technology median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
882.41%
Net income/share CAGR of 882.41% while Technology median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
108.68%
5Y net income/share CAGR > 1.5x Technology median of 8.44%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
1537.14%
3Y net income/share CAGR > 1.5x Technology median of 17.28%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
188.07%
Equity/share CAGR exceeding 1.5x Technology median of 26.54% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
162.02%
5Y equity/share CAGR > 1.5x Technology median of 15.39%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
99.34%
3Y equity/share CAGR > 1.5x Technology median of 7.09%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
10.49%
Dividend/share CAGR of 10.49% while Technology is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
27.18%
5Y dividend/share CAGR of 27.18% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.
-6.24%
Dividend reductions while Technology median grows. Seth Klarman sees a near-term disadvantage if peers maintain or raise payouts.
-5.96%
AR shrinking while Technology median grows. Seth Klarman sees potential advantage unless it signals declining demand.
18.73%
Inventory growth of 18.73% while Technology median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
13.87%
Asset growth exceeding 1.5x Technology median of 2.20%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
13.93%
BV/share growth exceeding 1.5x Technology median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
-0.91%
Debt is shrinking while Technology median is rising. Seth Klarman might see an advantage if growth remains possible.
-3.71%
R&D dropping while Technology median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.
28.49%
SG&A growth far above Technology median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.